Literature DB >> 18785015

Acute migraine in the Emergency Department: extending European principles of management.

Paolo Martelletti1, Ivano Farinelli, Timothy J Steiner.   

Abstract

The World Health Organization (WHO) placed migraine 19th among all causes of disability (12th in women) measured in years of healthy life lost to disability (YLD). The importance of headache disorders, particularly of the primary forms, is established by their distribution worldwide, their duration (the majority being life-long conditions) and their imposition of both disability and life-style restrictions among large numbers of people. For these reasons, headache disorders should represent a public-health priority. In the Emergency Department (ED), as elsewhere, migraine is often under-diagnosed-and under-treated when it is diagnosed. The result is likely to be failure of treatment. Particular attention to diagnosis is needed in ED patients with acute headache, since there is a higher probability of secondary headache due to underlying pathologies. According to European principles of management, acute migraine treatment generally is stepwise. Of the two main steps, the first relies on symptomatic medication, preferably NSAIDs with or without antiemetics. The second step uses specific therapies, usually triptans. Modifications to routine practice are appropriate in the ED. Parenteral administration of symptomatic therapies is a preferred first choice, whilst immediate resort to triptans may be appropriate, and achieve better outcomes, in patients with severe headache and diagnostic confirmation of migraine.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18785015     DOI: 10.1007/s11739-008-0188-1

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN: 1828-0447            Impact factor:   3.397


  5 in total

Review 1.  Headache-type adverse effects of NO donors: vasodilation and beyond.

Authors:  G Bagdy; P Riba; V Kecskeméti; D Chase; G Juhász
Journal:  Br J Pharmacol       Date:  2010-03-19       Impact factor: 8.739

2.  Opioids can be useful in the treatment of headache.

Authors:  Cinzia Finocchi; Erica Viani
Journal:  Neurol Sci       Date:  2013-05       Impact factor: 3.307

Review 3.  Future drugs for migraine.

Authors:  Ivano Farinelli; Sergio De Filippis; Gabriella Coloprisco; Serena Missori; Paolo Martelletti
Journal:  Intern Emerg Med       Date:  2009-06-24       Impact factor: 3.397

4.  Efficacy and tolerability of intravenous methylergonovine in migraine female patients attending the emergency department: a pilot open-label study.

Authors:  Alfredo I Niño-Maldonado; Gary Caballero-García; Wilfrido Mercado-Bochero; Fernando Rico-Villademoros; Elena P Calandre
Journal:  Head Face Med       Date:  2009-11-08       Impact factor: 2.151

5.  The Global Burden of Disease survey 2010, Lifting The Burden and thinking outside-the-box on headache disorders.

Authors:  Paolo Martelletti; Gretchen L Birbeck; Zaza Katsarava; Rigmor H Jensen; Lars J Stovner; Timothy J Steiner
Journal:  J Headache Pain       Date:  2013-02-15       Impact factor: 7.277

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.